SINTILIMAB
Clinical trials for SINTILIMAB explained in plain language.
Never miss a new study
Get alerted when new SINTILIMAB trials appear
Sign up with your email to follow new studies for SINTILIMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to fight tough brain cancers in frail patients
Disease control Recruiting nowThis study is testing whether a combination of three drugs—thiotepa, pirtobrutinib, and sintilimab—can help control a type of lymphoma that affects the brain or has returned after previous treatment. It is for adults who are frail or whose cancer has not responded to standard the…
Matched conditions: SINTILIMAB
Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug combo aims to stop liver cancer from coming back after surgery
Disease control Recruiting nowThis study is testing whether giving two drugs, sintilimab and bevacizumab, before surgery can help people with liver cancer that is more advanced but still removable. The goal is to shrink the tumor and, most importantly, lower the high chance of the cancer returning after the o…
Matched conditions: SINTILIMAB
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC